Analysis of Pemoline-Associated Hepatic Failure

J Gordon Millichap

doi:10.15844/pedneurbriefs-11-3-6

Analysis of Pemoline-Associated Hepatic Failure

Pediatric Neurology Briefs

Volume 11 (1997): Issue 3

By: J Gordon Millichap

Open Access

|Mar 1997

Abstract

A search of online computerized medical data-bases (Medline, Peruse) at McGill University, Montreal, Canada, revealed four reported cases of fatal fulminant hepatic failure (FHF) associated with pemoline (Cylert) use as a treatment for attention deficit hyperactivity disorder.

References

Shevell M Schreiber R Pemoline-associated hepatic failure: a critical analysis of the literature Pediatr Neurol 1997 Jan 16 1 14 16 10.1016/S0887-8994(96)00266-4 9044395
Open DOI Search in Google Scholar Back to article
Masters KJ Alternative medication for ADHD J Am Acad Child Adolesc Psychiatry 1997 Mar 36 3 301 302 10.1097/00004583-199703000-00002 9055505 Letter to editor
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-11-3-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 20 - 21

Published on: Mar 1, 1997

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Fatal Fulminant Hepatic Failure,

Pemoline,

Methylphenidate

© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 11 (1997): Issue 3